Comments
In a public-private partnership, Apollo Hospitals has signed an agreement with Eisai Pharmaceuticals, Japan, and HelpAge India to provide better access to medicines to the underprivileged elderly patients suffering from dementia and depression.
Dementia is a neuro-psychiatric disorder in which memory and other cognitive functions like thought, comprehension, language, arithmetic, judgment and insight deteriorate progressively. The patient often experiences confusion, personality change, behaviour change, impaired judgement, difficulty finding words and so on. Alzheimer's is the most common cause of dementia.
The scope of the agreement is to explore collaboration followed by research between the companies for improving the rate of prevention, screening, diagnosis, treatment and support of dementia and depression among the elderly in India. The MoU was signed by Dr Prathap C. Reddy, Chairman, Apollo Hospitals Group, Mr Haruo Naito, President and CEO of Eisai Co, and Mr Amal Ganguli, President, HelpAge India.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.